INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 425m ago
HOUSE PTR24m ago
SEC 13F24m ago
ROBINHOOD CHAIN24m ago
Corporate insider
FD

Faga Daniel

Director, President, CEOCIK 0001673528

EDGAR filingsOpen in network
Disclosed transactions39
Buys / sells0 / 11
Max Insider Score32
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
69.4K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    First Tracks Biotherapeutics, Inc.Director, President, CEO · Apr 22, 2026
  • Insider ofevidence
    ANAPTYSBIO, INCDirector, President, CEO · Jan 9, 2026
9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A
—
98.6K sh
Apr 20, 2026
Apr 22, 2026
traded Apr 20, 2026
+2d
SEC FORM 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
80.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

14
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
2,321 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
2,321 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
9,200 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
9,200 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
194.9K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
194.9K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
379.6K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
379.6K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
305.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
305.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
133.4K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
133.4K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
2,321 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
9,200 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
194.9K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
379.6K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
305.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
133.4K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

9
FD
Faga DanielDirector, President, CEO
TRAXFirst Tracks Biotherapeutics, Inc.
Grant or award
A—
17.9K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC FORM 4

Evidence

17
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$33K
550 sh
Mar 27, 2026Mar 27, 2026
traded Mar 27, 2026
+0dSEC FORM 4

Evidence

20
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$63K
1,012 sh
Mar 27, 2026Mar 27, 2026
traded Mar 27, 2026
+0dSEC FORM 4

Evidence

17
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$6,599
100 sh
Mar 27, 2026Mar 27, 2026
traded Mar 27, 2026
+0dSEC FORM 4

Evidence

17
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$29K
490 sh
Mar 27, 2026Mar 27, 2026
traded Mar 27, 2026
+0dSEC FORM 4

Evidence

20
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$203K
3,155 sh
Mar 27, 2026Mar 27, 2026
traded Mar 27, 2026
+0dSEC FORM 4

Evidence

20
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$198K
3,038 sh
Mar 27, 2026Mar 27, 2026
traded Mar 27, 2026
+0dSEC FORM 4

Evidence

20
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$215K
3,662 sh
Mar 27, 2026Mar 27, 2026
traded Mar 27, 2026
+0dSEC FORM 4

Evidence

20
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$164K
2,592 sh
Mar 27, 2026Mar 27, 2026
traded Mar 27, 2026
+0dSEC FORM 4

Evidence

9
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
34.3K sh
Mar 25, 2026Mar 27, 2026
traded Mar 25, 2026
+2dSEC FORM 4

Evidence

17
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$29K
510 sh
Mar 27, 2026Mar 27, 2026
traded Mar 27, 2026
+0dSEC FORM 4

Evidence

20
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$149K
2,570 sh
Mar 27, 2026Mar 27, 2026
traded Mar 27, 2026
+0dSEC FORM 4

Evidence

21
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Option exercise
M—
26.8K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence

32
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$639K
14.3K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC FORM 4

Evidence

13
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Option exercise
M—
26.8K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC FORM 4

Evidence